 |
 |

Ethanollike Properties of the Serotonergic Partial Agonist m-Chlorophenylpiperazine in Chronic Alcoholic Patients
Chawki Benkelfat, MD;
Dennis L. Murphy, MD;
James L. Hill, PhD
Laboratory of Clinical Science National Institute of Mental Health NIH Clinical Center, 10/3D41 Bethesda, MD 90892
David T. George, MD;
David Nutt, MD, PhD;
Markku Linnoila, MD, PhD
Laboratory of Clinical Sciences National Institute on Alcohol Abuse and Alcoholism NIH Clinical Center, 10/3D41 Bethesda, MD 90892
Arch Gen Psychiatry. 1991;48(4):383.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
Alcoholic patients have lower levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid1; decreased availability of the serotonin precursor, tryptophan2; and reduced serotonin concentrations in platelets.3 These findings have led to the hypothesis that a dysregulation in serotonin metabolism may be involved in the pathogenesis of alcoholism. To further explore this hypothesis, we studied alcoholic patients who abstained from alcohol. Behavioral, physiological, and endocrine responses to the metabolite of trazodone hydrochloride, meta-chlorophenylpiperazine (m-CPP) hydrochloride, were used as indexes of serotonin receptor function in alcoholic patients.4
Twenty-one male patients who fulfilled DSM-III-R criteria for alcohol dependence and Research Diagnostic Criteria for alcoholism were selected for the study. They were in good physical health, euthymic, and abstinent from alcohol for at least 3 weeks when the study began. After written, informed consent was obtained, normal saline solution (the placebo) was administered intravenously. Thirty minutes later, m-CPP (0.08
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|